Effects of Daily Intranasal Oxytocin in Patients With Autism Spectrum Disorder
Researchers conducted a 24-week phase 2 trial of intranasal oxytocin therapy in pediatric patients with autism spectrum disorder to divulge whether it would improve social functioning.